Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Synchron"


4 mentions found


Nov 30 (Reuters) - Elon Musk said on Wednesday a wireless device developed by his brain chip company Neuralink is expected to begin human clinical trials in six months. The company is developing brain chip interfaces that it says could enable disabled patients to move and communicate again. He then said at a conference in late 2021 that he hoped to start human trials this year. Neuralink has repeatedly missed internal deadlines to gain U.S. Food and Drug Administration (FDA) approval to start human trials, current and former employees have said. It received U.S. regulatory clearance for human trials in 2021 and has completed studies in four people in Australia.
Elon Musk said he plans to implant a Neuralink device in his brain once it's available to humans. The billionaire said on Wednesday that he expects Neuralink will start human trials in the next 6 months. The startup aims to create brain implants that can read and write brain activity. "You could have a Neuralink device implanted right now and you wouldn't even know. The founder of the brain computer startup reiterated his pledge to get an implant of the device on Twitter.
Neuralink's 'show & tell' delayed by one month, Elon Musk says
  + stars: | 2022-10-23 | by ( ) www.reuters.com   time to read: +1 min
Oct 23 (Reuters) - Billionaire Elon Musk said in a tweet on Sunday pushed back by a month the date for Neuralink's "show & tell" event to Nov. 30 and did not provide further information. loadingThe chief executive of electric car maker Tesla Inc (TSLA.O) and rocket developer SpaceX said in August that the event would be held on Oct. 31. Co-founded by Musk in 2016, San Francisco-based Neuralink aims to implant wireless brain computer chips to help cure neurological conditions like Alzheimer's, dementia and spinal cord injuries and fuse humankind with artificial intelligence. Musk approached brain chip implant developer Synchron Inc about a potential investment after he expressed frustration to Neuralink employees over their slow progress to win regulatory clearance for its devices. Register now for FREE unlimited access to Reuters.com RegisterReporting by Jose Joseph in Bengaluru; Editing by Lisa ShumakerOur Standards: The Thomson Reuters Trust Principles.
That's when I started reporting on them, and like any good nerd I was compelled by what scientists could learn with these "brain computer interfaces." The race for implantable brain chips has been a long, deliberate marathon. Graham Felstead, who has severe paralysis, was the first person to have a BCI inserted via the blood vessels. Brain chips will enable them to perform simple actions on their own and reduce the need for round-the-clock care. "When we started in 2015 and I was pitching venture capitalists on brain computer interfaces, no one knew what a brain computer interface was," says Matt Angle, the CEO of Paradromics.
Total: 4